Antimyeloma activity of heat shock protein-90 inhibition

We show that multiple myeloma (MM), the second most commonly diagnosed hematologic malignancy, is responsive to hsp90 inhibitors in vitro and in a clinically relevant orthotopic in vivo model, even though this disease does not depend on HER2/neu, bcr/abl, androgen or estrogen receptors, or other hsp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mitsiades, Constantine S., Mitsiades, Nicholas S., McMullan, Ciaran J., Poulaki, Vassiliki, Kung, Andrew L., Davies, Faith E., Morgan, Gareth, Akiyama, Masaharu, Shringarpure, Reshma, Munshi, Nikhil C., Richardson, Paul G., Hideshima, Teru, Chauhan, Dharminder, Gu, Xuesong, Bailey, Charles, Joseph, Marie, Libermann, Towia A., Rosen, Neal S., Anderson, Kenneth C.
Formato: Artigo
Idioma:Inglês
Publicado em: © 2006 by The American Society of Hematology 2006
Assuntos:
Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895907/
https://ncbi.nlm.nih.gov/pubmed/16234364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-03-1158
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados